This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Latour-Pérez J, de-Miguel-Balsa E.Cost effectiveness of fondaparinux in non-ST-elevation acute coronary syndrome. PharmacoEconomics 27: 585-595, No. 7, 2009
Rights and permissions
About this article
Cite this article
Fondaparinux outperforms enoxaparin on all counts. Pharmacoecon. Outcomes News 586, 9 (2009). https://doi.org/10.2165/00151234-200905860-00022
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905860-00022